SEC reporting owner

Miller-Rich Nancy SEC insider disclosures

Explore Miller-Rich Nancy's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001735084
Issuers
4
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

INTERCEPT PHARMACEUTICALS, INC.0001270073ICPTNoYes
Aldeyra Therapeutics, Inc.0001341235ALDXNoYes
Kadmon Holdings, Inc.0001557142KDMNNoYes
4D Molecular Therapeutics, Inc.0001650648FDMT, FMDTNoYes

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

2026-06-192026-06-17FDMTA50,000Not reported
2026-06-122026-06-09ALDXA3,318Not reported
2026-06-122026-06-09ALDXA70,000Not reported
2025-06-212025-06-17FDMTA22,500Not reported
2025-06-132025-06-10ALDXA2,413Not reported
2025-06-132025-06-10ALDXA62,728Not reported
2024-10-222023-04-12ALDXP509Not reported
2024-10-222021-05-03ALDXP413Not reported

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.